Alyeska Investment Group’s Terns Pharmaceuticals TERN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-150,000
Closed -$831K 654
2024
Q4
$831K Hold
150,000
﹤0.01% 503
2024
Q3
$1.25M Buy
+150,000
New +$1.25M 0.01% 449